These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

144 related items for PubMed ID: 1485914

  • 1. Mutational specificities of N-nitrosamines in a host-mediated assay: comparison with direct-acting N-nitroso compounds in vitro and an approach to deducing the nature of ultimate mutagens in vivo.
    Liu YX, Guttenplan JB.
    Mol Carcinog; 1992; 6(4):232-7. PubMed ID: 1485914
    [Abstract] [Full Text] [Related]

  • 2. High mutagenic activity of N-nitrosobis(2-oxopropyl)amine and N-nitrosobis(2-hydroxypropyl)amine in the host-mediated assay in hamsters: evidence for premutagenic methyl and hydroxylpropyl adducts.
    Guttenplan JB, Kokkinakis D.
    Carcinogenesis; 1993 Aug; 14(8):1621-5. PubMed ID: 8353845
    [Abstract] [Full Text] [Related]

  • 3. N-nitrosamines: bacterial mutagenesis and in vitro metabolism.
    Guttenplan JB.
    Mutat Res; 1987 Sep; 186(2):81-134. PubMed ID: 3306361
    [Abstract] [Full Text] [Related]

  • 4. Development of mutagenicity during degradation of N-nitrosamines by advanced oxidation processes.
    Mestankova H, Schirmer K, Canonica S, von Gunten U.
    Water Res; 2014 Dec 01; 66():399-410. PubMed ID: 25240607
    [Abstract] [Full Text] [Related]

  • 5. Nitrosamine-induced mutagenesis in Escherichia coli K12 (343/113). 1. Mutagenic properties of certain aliphatic nitrosamines.
    Rao TK, Allen BE, Winton W, Lijinsky W, Epler JL.
    Mutat Res; 1981 Jul 01; 89(3):209-15. PubMed ID: 7022195
    [Abstract] [Full Text] [Related]

  • 6. Carcinogenicity and mutagenicity of N-nitroso compounds.
    Lijinsky W.
    Mol Toxicol; 1987 Jul 01; 1(1):107-19. PubMed ID: 3329700
    [Abstract] [Full Text] [Related]

  • 7. Mutagenicity of isomeric alkanediazotates, precursors for ultimate alkylating species of carcinogenic N-nitroso compounds.
    Ukawa-Ishikawa S, Sawada A, Kasuya K, Mochizuki M.
    Mutat Res; 1998 Jan 13; 412(1):99-107. PubMed ID: 9508369
    [Abstract] [Full Text] [Related]

  • 8. Effects of cytosol on mutagenesis induced by N-nitrosodimethylamine, N-nitrosomethylurea and alpha-acetoxy-N-nitrosodimethylamine in different strains of Salmonella: evidence for different ultimate mutagens from N-nitrosodimethylamine.
    Guttenplan JB.
    Carcinogenesis; 1993 May 13; 14(5):1013-9. PubMed ID: 8504462
    [Abstract] [Full Text] [Related]

  • 9. Mutagenicity of alpha-hydroxy N-nitrosamines in V79 Chinese hamster cells.
    Mochizuki M, Osabe M, Anjo T, Takeda K, Suzuki E, Okada M.
    IARC Sci Publ; 1984 May 13; (57):715-9. PubMed ID: 6398304
    [Abstract] [Full Text] [Related]

  • 10. Mutagenesis by N-nitroso compounds in Salmonella typhimurium TA102 and TA104: evidence for premutagenic adenine or thymine DNA adducts.
    Guttenplan JB, Hu YC.
    Mutat Res; 1984 May 13; 141(3-4):153-9. PubMed ID: 6392880
    [Abstract] [Full Text] [Related]

  • 11. Metabolic activation capabilities of S9 and hepatocytes from uninduced rats to convert carcinogenic N-nitrosamines to mutagens.
    Rumruen K, Pool BL.
    Mutat Res; 1984 May 13; 140(2-3):147-53. PubMed ID: 6379440
    [Abstract] [Full Text] [Related]

  • 12. Metabolic activation of N-alkylnitrosamines in genetically engineered Salmonella typhimurium expressing CYP2E1 or CYP2A6 together with human NADPH-cytochrome P450 reductase.
    Kushida H, Fujita K, Suzuki A, Yamada M, Endo T, Nohmi T, Kamataki T.
    Carcinogenesis; 2000 Jun 13; 21(6):1227-32. PubMed ID: 10837014
    [Abstract] [Full Text] [Related]

  • 13. Participation of rat liver cytochrome P450 2E1 in the activation of N-nitrosodimethylamine and N-nitrosodiethylamine to products genotoxic in an acetyltransferase-overexpressing Salmonella typhimurium strain (NM2009).
    Yamazaki H, Oda Y, Funae Y, Imaoka S, Inui Y, Guengerich FP, Shimada T.
    Carcinogenesis; 1992 Jun 13; 13(6):979-85. PubMed ID: 1600620
    [Abstract] [Full Text] [Related]

  • 14. Mutagenicity of five cyclic N-nitrosamines: assay with Salmonella typhimurium.
    Stoltz DR, Sen NP.
    J Natl Cancer Inst; 1977 Feb 13; 58(2):393-4. PubMed ID: 319245
    [Abstract] [Full Text] [Related]

  • 15. Characterization of the CYP isozyme profile induced by cyclohexanol.
    Espinosa-Aguirre JJ, Rubio J, López I, Nosti R, Asteinza J.
    Mutagenesis; 1997 May 13; 12(3):159-62. PubMed ID: 9175641
    [Abstract] [Full Text] [Related]

  • 16. Isolation and structural identification of a direct-acting mutagen derived from N-nitroso-N-methylpentylamine and Fenton's reagent with copper ion.
    Miura M, Inami K, Yoshida M, Yamaguchi K, Mashino T, Mochizuki M.
    Bioorg Med Chem; 2011 Sep 15; 19(18):5693-7. PubMed ID: 21873073
    [Abstract] [Full Text] [Related]

  • 17. Mutagenicity of several pancreatic carcinogenic derivatives of N-nitrosodipropylamine in the Ames assay.
    Wislocki P, Gingell R.
    Mutat Res; 1980 Mar 15; 77(3):215-9. PubMed ID: 6991919
    [Abstract] [Full Text] [Related]

  • 18. Biological activity of benzylating N-nitroso compounds. Models of activated N-nitrosomethylbenzylamine.
    Wiessler M, Romruen K, Pool BL.
    Carcinogenesis; 1983 Mar 15; 4(7):867-71. PubMed ID: 6223716
    [Abstract] [Full Text] [Related]

  • 19. Enhanced mutagenic activities of N-nitroso compounds in weakly acidic media.
    Guttenplan JB.
    Carcinogenesis; 1980 May 15; 1(5):439-44. PubMed ID: 7023717
    [Abstract] [Full Text] [Related]

  • 20. Role of human cytochrome P450 (CYP) in the metabolic activation of N-alkylnitrosamines: application of genetically engineered Salmonella typhimurium YG7108 expressing each form of CYP together with human NADPH-cytochrome P450 reductase.
    Fujita K, Kamataki T.
    Mutat Res; 2001 Nov 01; 483(1-2):35-41. PubMed ID: 11600130
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.